AHNAK2 is a Biomarker and a Potential Therapeutic Target of Adenocarcinomas

Overview

Journal Acta Biochim Biophys Sin (Shanghai)

Specialties Biochemistry
Biophysics

Date 2022 Aug 26

PMID 36017889

Authors

Meng Xu

Anyi Cheng

Liya Yu

Wei Wei

Jinpeng Li

Cheguo Cai

Affiliations

Soon will be listed here.

Abstract

Adenocarcinoma is the second largest histological type of cervical cancer, second only to cervical squamous cell carcinoma. At present, despite the clinical treatment strategies of cervical adenocarcinoma and cervical squamous cell carcinoma being similar, the outcome and prognosis of cervical adenocarcinoma are significantly poor. Therefore, it is urgent to find specific biomarker and therapeutic target for cervical adenocarcinoma. In this study, we aim to reveal and verify the potential biomarkers and therapeutic targets of cervical adenocarcinoma. Weighted correlation network analysis (WGCNA) reveals the differentially-expressed genes significantly related to the histological characteristics of the two cervical cancer subtypes. We select the genes with the top 20 significance for further investigation. Through microarray and immunohistochemical (IHC) analyses of a variety of tumor tissues, we find that among these 20 genes, is highly expressed not only in cervical adenocarcinoma, but also in multiple of adenocarcinoma tissues, including esophagus, breast and colon, while not in normal gland tissues. , knockdown significantly inhibits cell proliferation and migration of adenocarcinoma cell lines. , knockdown significantly inhibits tumor progression and metastasis of various adenocarcinomas. RNA-sequencing and bioinformatics analyses suggest that the inhibitory effect of knockdown on tumor progression is achieved by regulating DNA replication and upregulating Bim expression. Together, we demonstrate that AHNAK2 is a biomarker and a potential therapeutic target for adenocarcinomas.

Citing Articles

AHNAKs roles in physiology and malignant tumors.

Zhang S, Cai Z, Li H Front Oncol. 2023; 13:1258951.

PMID: 38033502 PMC: 10682155. DOI: 10.3389/fonc.2023.1258951.

Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms.

Guarrera L, Kurosaki M, Garattini S, Gianni M, Fasola G, Rossit L J Exp Clin Cancer Res. 2023; 42(1):298.

PMID: 37951921 PMC: 10638833. DOI: 10.1186/s13046-023-02869-w.

References

Xue Z, Huang K, Cai C, Cai L, Jiang C, Feng Y . Genetic programs in human and mouse early embryos revealed by single-cell RNA sequencing. Nature. 2013; 500(7464):593-7. PMC: 4950944. DOI: 10.1038/nature12364. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Campbell J, Alexandrov A, Kim J, Wala J, Berger A, Pedamallu C . Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016; 48(6):607-16. PMC: 4884143. DOI: 10.1038/ng.3564. View

Luo Y, Coskun V, Liang A, Yu J, Cheng L, Ge W . Single-cell transcriptome analyses reveal signals to activate dormant neural stem cells. Cell. 2015; 161(5):1175-1186. PMC: 4851109. DOI: 10.1016/j.cell.2015.04.001. View

Cohen P, Jhingran A, Oaknin A, Denny L . Cervical cancer. Lancet. 2019; 393(10167):169-182. DOI: 10.1016/S0140-6736(18)32470-X. View

Wang M, Li X, Zhang J, Yang Q, Chen W, Jin W . AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma. Theranostics. 2017; 7(5):1100-1113. PMC: 5399579. DOI: 10.7150/thno.18198. View

Liu X, Fuentes E . Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition. Int Rev Cell Mol Biol. 2019; 343:129-218. PMC: 7185565. DOI: 10.1016/bs.ircmb.2018.05.013. View

Song Y, Li L, Ou Y, Gao Z, Li E, Li X . Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014; 509(7498):91-5. DOI: 10.1038/nature13176. View

Hoadley K, Yau C, Wolf D, Cherniack A, Tamborero D, Ng S . Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014; 158(4):929-944. PMC: 4152462. DOI: 10.1016/j.cell.2014.06.049. View

10.

Shtivelman E, Cohen F, Bishop J . A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc Natl Acad Sci U S A. 1992; 89(12):5472-6. PMC: 49314. DOI: 10.1073/pnas.89.12.5472. View

11.

Lin E, Karakasheva T, Lee D, Lee J, Long Q, Bass A . Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundaries. PLoS Genet. 2017; 13(8):e1006938. PMC: 5560753. DOI: 10.1371/journal.pgen.1006938. View

12.

Rivera-Colon G, Chen H, Niu S, Lucas E, Holloway S, Carrick K . Cervical Adenocarcinoma: Histopathologic Features From Biopsies to Predict Tumor Behavior. Am J Surg Pathol. 2019; 44(2):247-254. DOI: 10.1097/PAS.0000000000001379. View

13.

Sanchez-Danes A, Blanpain C . Deciphering the cells of origin of squamous cell carcinomas. Nat Rev Cancer. 2018; 18(9):549-561. PMC: 7170720. DOI: 10.1038/s41568-018-0024-5. View

14.

Buchheit C, Weigel K, Schafer Z . Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer. 2014; 14(9):632-41. DOI: 10.1038/nrc3789. View

15.

Bhasin M, Ndebele K, Bucur O, Yee E, Otu H, Plati J . Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. Oncotarget. 2016; 7(17):23263-81. PMC: 5029625. DOI: 10.18632/oncotarget.8139. View

16.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

17.

Sun S, Yang H, Wang F, Zhao S . Oct4 downregulation-induced inflammation increases the migration and invasion rate of oral squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai). 2021; 53(11):1440-1449. DOI: 10.1093/abbs/gmab127. View

18.

Li M, Liu Y, Meng Y, Zhu Y . AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells. Cancer Biother Radiopharm. 2019; 34(10):626-633. DOI: 10.1089/cbr.2019.2778. View

19.

Komuro A, Masuda Y, Kobayashi K, Babbitt R, Gunel M, Flavell R . The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells. Proc Natl Acad Sci U S A. 2004; 101(12):4053-8. PMC: 384694. DOI: 10.1073/pnas.0308619101. View

20.

Yang Z, Liu Y, Zhou X . An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer. Med Sci Monit. 2020; 26:e921769. PMC: 7148424. DOI: 10.12659/MSM.921769. View